N-(6-((2,5-Dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-6-((5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno(3,4-d)imidazol-4-yl)pentanoyl)amino)hexanamide → Biotinyl-lysine

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	N-(6-((2,5-Dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-6-((5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno(3,4-d)imidazol-4-yl)pentanoyl)amino)hexanamide	HCID 16219024	—
Edukt	Maleimide-biotin	HCID 22896102	—
Produkt	Biotinyl-lysine	HCID 18644438	—

Reaktionsschritte

and 6-(biotinamidocaproylamido) caproic acid N-hydroxysuccinimide ester (Sigma-Aldrich, product B3295), biotinamidocaproate-N-hydroxysuccinimide ester (Sigma-Aldrich, product B2643), biotinamidocaproic acid 3-sulfo-N-hydroxysuccinimide ester (Sigma-Aldrich, product B1022) and biotin-maleimide (Sigma-Aldrich, product B1267).

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US07977500B2
Quelldatensatz	uspto-grants-2011_07
ORD ID	ord-1756a72e762b453c9241dd0accd58490
Quellennotiz	uspto-grants-2011_07